Orange Book: approved drug products with therapeutic equivalence evaluations. Accessed March 26, 2025. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
FDA. Compounding and the FDA: Questions and Answers. Accessed March 26, 2025. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1-8.
Schiele JT, Quinzler R, Klimm HD, Pruszydlo MG, Haefeli WE. Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms. Eur J Clin Pharmacol. 2013;69(4):937-948.
Nidanapu RP, Rajan S, Mahadevan S, Gitanjali B. Tablet splitting of antiepileptic drugs in pediatric epilepsy: potential effect on plasma drug concentrations. Paediatr Drugs. 2016;18(6):451-463.
Report: limited FDA survey of compounded drug products. US Food and Drug Administration website. Accessed March 26, 2025. https://www.fda.gov/drugs/human-drug-compounding/ report-limited-fda-survey-compounded-drug-products
Pharmacy compounding of human drug products under section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance. June 2016. US Food and Drug Administration website. Accessed March 26, 2025. https://www.fda.gov/media/94393/download
Krauss GL, Caffo B, Chang YT, Hendrix CW, Chuang K. Assessing bioequivalence of generic antiepilepsy drugs. Ann Neurol. 2011;70(2):221-228.
Epilepsy Society. Generic and branded anti-seizure medications. Accessed March 26, 2025. https://epilepsysociety.org.uk/about-epilepsy/anti-seizure-medication/generic-branded
Epilepsies: diagnosis and management. London: National Institute for Health and Care Excellence (NICE); 2021 May 12. PMID: 32027473.
Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav. 2008;13(4):693-699.
Miller E. Topamax. Drugwatch website. Accessed March 26, 2025. https://www.drugwatch.com/topamax/
Fine A, Wirrell EC. Seizures in children. Pediatr Rev. 2020;41(7):321-347.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Epilepsy Curr. 2018;18(4):260-268.
Ostendorf A, Ng YT. Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions. Neuropsychiatr Dis Treat. 2017;13:1131-1140.
Silberstein SD, Neto W, Schmitt J, Jacobs D; for the MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61(4):490-495.
American Academy of Neurology. Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults. Accessed March 26, 2025. https://www.aan.com/Guidelines/Home/GuidelineDetail/536
Lisi OM. Pros and cons of pharmacy compounding. U.S. Pharmacist. 2021. Accessed March 26, 2025. https://www.uspharmacist.com/article/pros-and-cons-of-pharmacy-compounding-1?wc_mid=6220:682315&wc_rid=6220:14308443
Billstein-Leber M, Carrilo JD, Cassano AT, et al. Am J Health-Syst Pharm. 2018;75(19):1493-1517.
NIOSH [2016]. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016. Publication Number 2016-161 (Supersedes 2014-138). Accessed March 8, 2024. https://www.cdc.gov/niosh/docs/2016-161/default.html
Allen LV. Topiramate 20 mg/mL oral suspension. US Pharm. 2017;42(5):46-47.
USP General Chapter <800> Hazardous drugs–handling in healthcare settings. July 1, 2020.
Institute for Safe Medication Practices. List of oral dosage forms that should not be crushed. Published February 21, 2020. Accessed August 16, 2022.
Best Pharmaceuticals for Children Act (BPCA) Priority List of Needs in Pediatric Therapeutics. Accessed March 26, 2025. https://www.nichd.nih.gov/research/supported/bpca/historical-initiatives#body_accordion-1116
Gutierrez-Colina AM, Smith AW, Mara CA, Modi AC. Adherence barriers in pediatric epilepsy: from toddlers to young adults. Epilepsy Behav. 2018;80:229-234.
Polaha J, Dalton WT 3rd, Lancaster BM. Parental report of medication acceptance among youth: implications for everyday practice. South Med J. 2008;101(11):1106-1112.
Gibbs SN, Choi J, Khilfeh I, Ahmed KH, et al. The humanistic and economic burden of pediatric focal seizures in the United States. J Child Neurol. 2020;35(8):543-555.
Chappell F. Medication adherence in children remains a challenge. Prescriber. 2015;26(12):31-34.
McGrady ME, Hommel KA. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics. 2013;132(4):730-740.
Gidal BE, Resnick T, Smith MC, Wheless JW. Zonisamide: a comprehensive, updated review for the clinician. Neurol Clin Pract. 2024;14(1): e200210.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(24):1117.
Sills G, Brodie M. Pharmacokinetics and drug interactions with zonisamide. Epilepsia. 2007;48(3):435-441.
Stević I, Petrović N, Janković SM. Bioequivalence of different formulations of zonisamide oral suspensions: a short review. Patient Prefer Adherence. 2023;17:2841-2845.
Heitman T, Day AJ, Bassani AS. Pediatric compounding pharmacy: taking on the responsibility of providing quality customized prescriptions. Children (Basel). 2019;6(5):66.
Data on file. Azurity Pharmaceuticals, Inc.
Wright D, Tomlin S. CPD-How to help if a patient can’t swallow. Pharmaceutical Journal. 2011;286(7643):271.
Radhakrishnan C, Sefidani Forough A, Cichero JAY, et al. A difficult pill to swallow: an investigation of the factors associated with medication swallowing difficulties. Patient Prefer Adherence. 2021;15:29-40.
